A role for T lymphocytes in tumour inhibition and enhancement caused by systemic administration of Corynebacterium parvum.
D000818:Animals; D000918:Antibody Specificity; D002471:Cell Transformation, Neoplastic; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D005354:Fibrosarcoma / Q000628:therapy*; D008175:Lung Neoplasms / Q000628:therapy; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D011425:Propionibacterium acnes; D011828:Radiation Chimera; D013163:Splenomegaly / Q000209:etiology; D013601:T-Lymphocytes / Q000503:physiopathology*